Pharmacovigilance of thalidomide in the Brazilian Health System and patient safety

• Prif Awduron: Paula Lana de Miranda Drummond (Awdur), Roberta Márcia Marques dos Santos (Awdur), Cristine de Araújo Silva (Awdur), Cristiane Aparecida Menezes de Pádua (Awdur)
• Fformat: Llyfr
• Cyhoeddwyd: Universidade de São Paulo, 2021-04-01T00:00:00Z.
• Pynciau: article
• Mynediad Ar-lein: Connect to this object online.

In Brazil, thalidomide is manufactured by a public laboratory, distributed by the Unified Health System (SUS), and regulated by the National Health Surveillance Agency (Anvisa). Despite the concerns regarding the adverse effects of thalidomide, few drug utilization studies have been conducted to des...